Our News on Newswise

Exploitation of supply chain monitoring loopholes fueled US opioid epidemic, study finds

New research from the Indiana University Kelley School of Business explains how pharmaceutical companies were able to saturate the country with massive quantities of opioids, despite efforts by the Drug Enforcement Administration to regulate their...
24-Jun-2024 9:05 AM EDT Add to Favorites

Newswise: 66744af33faa6_Kapur700x500.png

Acute myeloid leukemia discovery tackles drug-resistant gene mutations

Indiana University School of Medicine researchers and their collaborators have uncovered molecular insights expected to enhance treatment options for acute myeloid leukemia (AML), a rare and severe blood and bone marrow cancer.
20-Jun-2024 11:05 AM EDT Add to Favorites

Newswise: 667077293621d_yoshi.PNG

$2.6 million in grant funding to support research on genetic causes of blindness

Indiana University School of Medicine’s Yoshikazu Imanishi, PhD, was recently awarded a four-year, $2.1 million grant from the National Eye Institute and a three-year, $500,000 grant from the Foundation Fighting Blindness to study genetic causes...
18-Jun-2024 8:00 AM EDT Add to Favorites

Newswise: 665f2933107c1_SumuduWatugalaphoto.jpg

Investors generally underestimated the risk and impact of hurricanes, prior to feeling “Superstorm” Sandy’s fury on Wall Street

In a paper forthcoming in the Journal of Finance, professors at the Indiana University Kelley School of Business, studied firm-level exposures to hurricanes over a 24-year period to better understand how extreme weather events impact performance in...
4-Jun-2024 10:05 AM EDT Add to Favorites

Chemotherapy type can be personalized to decrease harmful side effects for Black patients with breast cancer

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the IU School of Medicine have discovered that Black patients with breast cancer who are treated with a chemotherapy called docetaxel experience less of a...
3-Jun-2024 9:05 AM EDT Add to Favorites

Newswise: 66476005570d0_MichaelD.DavisPhD7.jpg

IU School of Medicine researchers to present respiratory therapy advancements at ATS 2024

Researchers will showcase promising respiratory disease research at the American Thoracic Society (ATS) 2024 International Conference and ATS 2024 Respiratory Innovation Summit (RIS), May 17-22 in San Diego, California.
17-May-2024 9:05 AM EDT Add to Favorites

Newswise: 663a4ddd2e8cb_23629-chang-hyun-gil.png

Biomarker found to help identify cells that can repair damaged blood vessels

Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with endothelial dysfunction, a...
8-May-2024 8:00 AM EDT Add to Favorites

Newswise: 662a9f53cc7c5_779585af-0952-4b0f-9486-730b5767581b.png

$2.7 million grant to explore hypoxia’s impact on blood stem cells

Indiana University School of Medicine scientists are on a mission to understand why hematopoietic stem cells, responsible for producing all types of mature blood cells, exhibit better responses in a low-oxygen environment within the bone marrow,...
26-Apr-2024 8:00 AM EDT Add to Favorites

See All News


Founded in 1820, Indiana University is one of the world's foremost public institutions. With more than 111,000 students and 19,000 employees statewide, IU continues to pursue its core missions of education and research while building a foundation for the university's enduring strengths in teaching and learning, world-class scholarship, innovation, creative activity, community engagement and academic freedom. Bloomington is the flagship campus of the university, and each one of IU's seven campuses is an accredited, four-year degree-granting institution.